Pharma & Life Sciences
Companies at Innovations and State of the Art in Alzheimer's & Dementia (ISAD)
28 organisations are named on published listings for Innovations and State of the Art in Alzheimer's & Dementia (ISAD): 28 companies on stage.
From the listings Innovations and State of the Art in Alzheimer's & Dementia (ISAD) prints on its own site. No registration data, and no individual attendees.
The essentials
Event details
- Dates
- October 2026
- Location
- Paris, France
- Industry
- Pharma & Life Sciences
- Companies listed
- 28
From the speaker listing
Companies on stage (28)
Organisations named beside a speaker on the speaker listings published for Innovations and State of the Art in Alzheimer's & Dementia (ISAD).
- University of Texas at El Paso
- Weill Cornell Medicine
- University of Kansas
- Telocyte
- University of Illinois
- University of South Alabama
- Rush University Medical Center
- University of Uppsala
- Arizona State University
- University of Toronto
- University Vita-Salute San Raffaele
- University of British Columbia
- Umeå University
- University of Pennsylvania
- Laval University
- Tel Aviv University
- Louisiana State University Health Sciences Center
- Harvard University
- COSPECS- University of Messina
- NYU Grossman School of Medicine
- University of Massachusetts Boston
- University of Sri Jayewardenepura
- University of Otago
- SunRegen Healthcare AG
- remynd
- Aloïs Association
- University of Southern California
- Alzheimer's Research and Prevention Foundation
Last checked 2026-09-10.
Agenda themes
Topics covered
- Living with Alzheimer’s & Dementia: The Experiences
- Dementia diagnosis, treatment
- Risk reduction and prevention
- Behavioural and psychological symptoms of dementia
- Dementia & Mental health
- Dementia and Geriatric Cognitive Disorders
- Vascular Dementia, Aging and Dementia
- Neurodegenerative Diseases
- Advances in Alzheimer’s and Dementia Research
- Alzheimers Research and Therapy
- Parkinson’s disease and Alzheimer's disease
- Memory Processes and Neural Plasticity
Ahead of the event
From the published list to a ranked target list
Published listings for Innovations and State of the Art in Alzheimer's & Dementia (ISAD) name 28 organisations, 28 companies on stage. Your team needs the people in them who match your ICP, ranked, with account context, in the sequencer it already uses. Luminik sources the attendee picture from the event's public directory and the organisations around it, enriches it against your ICP, and sequences it weeks ahead of the event. Capture at the event writes straight to Salesforce or HubSpot the same day, and attribution ties the pipeline back to the spend.
Common questions
Frequently asked
- Which companies attend Innovations and State of the Art in Alzheimer's & Dementia (ISAD)?
- 28 organisations are named on published listings for Innovations and State of the Art in Alzheimer's & Dementia (ISAD): 28 companies on stage, including University of Texas at El Paso, Weill Cornell Medicine, University of Kansas, Telocyte, University of Illinois. That is the listed line-up rather than a registration list, so it names no individual attendee.
- When and where is Innovations and State of the Art in Alzheimer's & Dementia (ISAD)?
- October 2026 at Paris, France.
Innovations and State of the Art in Alzheimer's & Dementia (ISAD) is a trademark of its organiser. This page is an independent summary of listings published for the event. Being listed here is not an endorsement of the event, of Luminik, or of anything else. Luminik is not affiliated with the event.